Association between anemia and COPD in Iranian population

International Journal of Hematology-Oncology and Stem Cell Research

Volumn 7, Issue 2, 2013, Pages 6-10

  Zavarreh, Roshanak Hasheminasab ^a   Zahmatkesh, Mohammad Mehdi ^a   Vakili, Masood ^a   Shahriari Ahmadi, Ali ^a   Zohal, Mohammad Ali ^b   Arabi, Mohsen ^a   Mahmoudian, Alireza ^c   Gheisuri, Abbas ^a   Kian, Abdolhamed ^a   Fahimi, Ali ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Microbiology Department of Oroumieh University   (Iran)

Author keywords

Anemia; COPD

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; ERYTHROCYTE COUNT; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; IRAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PREVALENCE; QUALITY OF LIFE; SCHOOL CHILD; SMOKING; SPIROMETRY; TEACHING HOSPITAL;

EID: 84876523473     PISSN: 17351243     EISSN: 20082207     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Krishnan G, Grant BJ, Muti PC, Mishra A, Ochs-Balcom HM, Freudenheim JL. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med. 2006 Sep 5; 6:23.
2. Almagro P, Calbo E, OchoadeEchaguen A, Mortality after hospitalization for COPD. Chest 2002; 121:1441-1448.
3. Gerardi DA, Lovett L, Benoit-Connors ML, Reardon JZ, Zu Wallack RL. Variables related to increased mortality Following out-patient pulmonary rehabilitation. Eur Respir J 1996;9:431-435.
4. Hersh CP, DeMeo DL, Al-Ansari E, Predictors of survival in severe, early onset COPD. Chest 2004; 126:1443-1451.
5. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive Pulmonary disease. Am J Respir Crit Care Med 1999;160: 1856-1861.
6. John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD. Chest. 2005 Mar; 127(3):825-9.
7. Mascitelli L, Pezzetta F. Anemia and COPD. Chest. 2005 Oct; 128(4):3084.
8. Standardization of spirometry 1994 update, American thoracic society Amj Respiv erit care med 1995, 152 (3):7107-1136
9. Hurd s, pauwels R. Global initiative for chronic obstructive long diseases (GOLD) pulm pharmacol ther 2002,15(4):353-355.
10. Halpern MT, Zilberberg MD, Schmier JK, Lau EC, Shorr AF. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc. 2006 Oct 16; 4:17.
11. American thoracic society standards for the diagnosis & care of patients with chronic obstructive pulmonary disease. Amj respircit care med. 1995; 152: 77-121.
12. Penninx BW, Pahor M, Cesari M, et al. Anaemiais Associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 2004; 52:719-724.
13. Mansen TJ, McCance KL, Parker-Cohen PD. Alterations of erythrocyte function. In: McCance KL, Huether SE, eds. Pathophysiology. The Biologic Basis for Disease in Adults and Children. 2nd Edn. St. Louis, Mosby-Year BookInc., 1994;pp.860-877.
14. Reilly JJ, Edwin JR, Silverman K, et al. Chronic obstructive pulmonary disease in: Braunwald, Fauci, Kasper et al (editors), Harrisons principals of internal medicine,18th ed, New York. Mc Graw hill 2012.p.1635-1643
15. Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007 May; 29(5):923-9.
16. John M, Lange A, Hoernig S, Witt C, Anker SD. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol. 2006 Aug 28; 111(3):365-70.
17. Kilburn KH, Asmundsson T. Factors influencing the course of COPD. Postgrad Med. 1973 Sep; 54(3):135-41.
18. Shorr AF, Doyle J, Stern L, Dolgitser M, Zilberberg MD. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin. 2008 Apr; 24(4):1123-30.
19. Similowski T, Agustí A, MacNee W, Schönhofer B. The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006 Feb; 27(2):390-6.
20. Chambellan A, Chailleux E, Similowski T; ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest. 2005 Sep; 128(3):1201-8.
21. Singh A. Is 13 g. dL(-1) the threshold to correct anaemia in COPD Eur Respir J. 2007;30(5):1024-5.
22. Pavlisa G, Vrbanic V, Kusec V, Jaksic B. Erythropoietin response after correction of severe hypoxaemia due to acute respiratory failure in chronic obstructive pulmonary disease patients. Clin Sci (Lond). 2004 Jan; 106(1):43-51.
23. Schols AM. Pulmonary cachexia. Int J Cardiol 2002; 85:101-110.
24. Means RT Jr. Advances in the anemia of chronic disease. Int J Hematol 1999; 70:7-12.
25. Marathias KP, Agroyannis B, Mavromoustakos T, et al. Hematocrit-lowering effect following inactivation of rennin angiotensin system with angiotensin converting enzymeinHibitors and angiotensin receptor blockers. Curr Top Med Chem2004;4:483-486
26. Ishani A, Weinhandl E, Zhao Z, et al. Angiotensin converting enzyme inhibitor as arisk factor for the development of anemia, and the impact of incident anemia on mortality in patients with Left ventricular dysfunction. Jam Coll Cardiol 2005;45:391-399